TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 19:59 | 11/19/24 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gall Matthew | MA | O | CFO | P | 39 | 7.73 | 0 | 5 | 8 | 65 | D | ||||||||||||||
10/12/23 17:09 | 10/12/23 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gall Matthew | MA | O | CFO | P | 42 | 8.37 | 0 | 5 | 35 | 19 | D | ||||||||||||||
12/28/21 20:58 | 12/27/21 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gall Matthew | MA | O | CFO | S | -232 | 46.45 | 0 | -5 | -26 | 14 | D | ||||||||||||||
10/12/21 20:02 | 10/11/21 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gall Matthew | MA | O | CFO | M.d | 89 | 6.16 | 0 | 14 | 289 | 19 | D | ||||||||||||||
6/16/21 18:46 | 6/16/21 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gall Matthew | MA | O | CFO | P | 130 | 26.09 | 0 | 5 | New | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |